Sleep Apnea

HONOLULU — Heart failure and sleep apnea-related mortality significantly increased over the last 2 decades, with greater risks among the elderly, men and Black individuals, according to data presented at the CHEST Annual Meeting.

The FDA asked for more testing regarding the recall of certain Philips Respironics ventilators, bilevel positive airway pressure machines and continuous positive airway pressure machines, according to an update from the agency.

Good adherence to continuous positive airway pressure therapy may reduce risk for major adverse cardiac and cerebrovascular events in secondary prevention of CVD in patients with obstructive sleep apnea, researchers reported.

The risk for death and hospitalizations due to cardiovascular disease in patients with obstructive sleep apnea decreased with use of CPAP, according to a presentation at the European Respiratory Society International Congress.

The likelihood for nocturnal gastroesophageal reflux, wheeze and cough declined with use of positive airway pressure for 2 years in patients with obstructive sleep apnea, according to results published in ERJ Open Research.

A new consensus guideline recommend screening women during pregnancy who have high risk for obstructive sleep apnea, such as those with obesity, hypertension or diabetes.

Obstructive sleep apnea-related increases in hypoxic and ventilatory burdens heightened the risk for cardiovascular disease, according to results published in American Journal of Respiratory and Critical Care Medicine.

A combination of atomoxetine and oxybutynin taken for 30 days lowered baseline obstructive sleep apnea severity, according to results published in Annals of the American Thoracic Society.

When evaluating oxygen desaturation index scores with 4% desaturation, sleep-disordered breathing was found more often in men with vs. without HIV, according to study results published in CHEST.